INNOVUS PHARMACEUTICALS, INC.: 10-Q filed 2017-08-14

Name: INNOVUS PHARMACEUTICALS, INC.: 10-Q filed 2017-08-14
Creator: INNOVUS PHARMACEUTICALS, INC.
License: https://creativecommons.org/licenses/by/4.0/

What INNOVUS PHARMACEUTICALS, INC. reported in its quarterly report filed 2017-08-14 (fiscal Q2 2017): 34 published measures, 91 facts as tagged in accession 0001654954-17-007532.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-08-14
Fiscal period: fiscal Q2 2017
Accession: 0001654954-17-007532 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All INNOVUS PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-06-30	8,414,289	USD
At 2016-12-31	8,227,378	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2017-06-30	6,369,667	USD
At 2016-12-31	7,133,405	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2017-06-30	2,044,622	USD
At 2016-12-31	1,093,973	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	-1,134,050	USD	91
2017-01-01 to 2017-06-30	-3,679,837	USD	181
2016-04-01 to 2016-06-30	-4,360,340	USD	91
2016-01-01 to 2016-06-30	-5,915,309	USD	182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2017-01-01 to 2017-06-30	-969,292	USD	181
2016-01-01 to 2016-06-30	256,152	USD	182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2017-01-01 to 2017-06-30	8,048	USD	181
2016-01-01 to 2016-06-30	6,565	USD	182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	2,038,657	USD	91
2017-01-01 to 2017-06-30	4,215,947	USD	181
2016-04-01 to 2016-06-30	1,019,520	USD	91
2016-01-01 to 2016-06-30	1,244,983	USD	182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2017-01-01 to 2017-06-30	1,972,040	USD	181
2016-01-01 to 2016-06-30	-107,355	USD	182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2017-01-01 to 2017-06-30	-8,048	USD	181
2016-01-01 to 2016-06-30	-6,565	USD	182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-06-30	-32,815,586	USD
At 2016-12-31	-29,135,749	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	3,200	USD	91
2017-01-01 to 2017-06-30	3,200	USD	181
2016-04-01 to 2016-06-30	0	USD	91
2016-01-01 to 2016-06-30	0	USD	182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2017-06-30	32,197	USD
At 2016-12-31	29,569	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	-1,122,956	USD	91
2017-01-01 to 2017-06-30	-2,781,339	USD	181
2016-04-01 to 2016-06-30	-442,393	USD	91
2016-01-01 to 2016-06-30	-1,660,286	USD	182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-06-30	2,826,509	USD
At 2016-12-31	2,327,028	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	110,130	USD	91
2017-01-01 to 2017-06-30	667,609	USD	181
2016-04-01 to 2016-06-30	1,860,399	USD	91
2016-01-01 to 2016-06-30	2,251,250	USD	182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-06-30	3,849,288	USD
At 2016-12-31	4,031,082	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2017-06-30	952,576	USD
At 2016-12-31	952,576	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2017-06-30	4,588,049	USD
At 2016-12-31	4,903,247	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2017-06-30	21,148	USD
At 2016-12-31	33,575	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	3,161,613	USD	91
2017-01-01 to 2017-06-30	6,997,286	USD	181
2016-04-01 to 2016-06-30	1,461,913	USD	91
2016-01-01 to 2016-06-30	2,905,269	USD	182

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2017-06-30	586,455	USD
At 2016-12-31	599,856	USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	15,063	USD	91
2017-01-01 to 2017-06-30	18,246	USD	181
2016-04-01 to 2016-06-30	3,892	USD	91
2016-01-01 to 2016-06-30	3,892	USD	182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-06-30	151,027,774	shares
At 2016-12-31	121,694,293	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2017-06-30	34,709,180	USD
At 2016-12-31	30,108,028	USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2017-06-30	924,040	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2017-06-30	4,588,049	USD
At 2016-12-31	4,903,247	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	-1,130,850	USD	91
2017-01-01 to 2017-06-30	-3,676,637	USD	181
2016-04-01 to 2016-06-30	-4,360,340	USD	91
2016-01-01 to 2016-06-30	-5,915,309	USD	182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	1,182,235	USD	91
2017-01-01 to 2017-06-30	2,886,898	USD	181
2016-04-01 to 2016-06-30	945,572	USD	91
2016-01-01 to 2016-06-30	2,233,309	USD	182

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2017-01-01 to 2017-06-30	5,420	USD	181
2016-01-01 to 2016-06-30	7,370	USD	182

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	157,473	USD	91
2017-01-01 to 2017-06-30	315,198	USD	181
2016-04-01 to 2016-06-30	178,083	USD	91
2016-01-01 to 2016-06-30	335,685	USD	182

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	-206	USD	91
2017-01-01 to 2017-06-30	-822	USD	181
2016-04-01 to 2016-06-30	111	USD	91
2016-01-01 to 2016-06-30	1,876	USD	182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	-7,894	USD	91
2017-01-01 to 2017-06-30	-895,298	USD	181
2016-04-01 to 2016-06-30	-3,917,947	USD	91
2016-01-01 to 2016-06-30	-4,255,023	USD	182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-06-30	8,151	USD	181
2016-01-01 to 2016-06-30	55,242	USD	182

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-06-30	13,401	USD	181
2016-01-01 to 2016-06-30	32,006	USD	182

Inspect the source

Entity: INNOVUS PHARMACEUTICALS, INC. / CIK 0001411879
Captured: 2026-09-22 19:47 UTC
SEC response SHA-256: e77a101a672b8634c33f41442578c32e719835a043b28e20b379158f9e2f8bab

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001411879.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))